Journal
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
Volume 20, Issue 3, Pages 237-241Publisher
TERMEDIA PUBLISHING HOUSE LTD
DOI: 10.5114/wo.2016.61567
Keywords
vitamin E; chemotherapy; neuropathy; prevention; meta-analysis
Categories
Ask authors/readers for more resources
Aim of this study: Chemotherapy-induced peripheral neuropathy (CIPN) is a major complication of cancer patients with chemotherapy. Although many interventions have been evaluated in previous studies, findings are controversial. The aim of this meta-analysis is to assess the efficacy of vitamin E supplementation in preventing CIPN. Material and methods: The electronic databases MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were systematically searched from their inception to December 31, 2013 to identify relevant randomised controlled trials. Two reviewers independently scanned and extracted the data of included studies. Review Manager 5.2 was used to analyse data. Results: Six articles involving 353 patients were included in meta-analysis. The results showed that vitamin E supplementation did not appear to significantly decrease the incidence of CIPN (relative risk (RR), 0.55; 95% confidence interval (CI), 0.29 to 1.05; p = 0.07), with significant heterogeneity (I-2 = 77%). However, Vitamin E supplementation can significantly prevent cisplatin associated neurotoxicity (RR, 0.31; 95% CI, 0.17 to 0.58; p = 0.0002), with no heterogeneity (I-2 = 0%). Conclusions: Vitamin E administration dose not decrease the incidence of CIPN. However, additional randomised controlled trials using large samples are needed to confirm the role of vitamin E supplementation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available